- Benzinga•2 years ago
Marijuana stocks were among the most volatile in 2014, riding a wave of interest created by legalization in Colorado and Washington, only to crash back down to about where the move began. 2015 is likely ...
- Marketwired•2 years ago
Australian research that has produced a line of insulin producing cells that could eliminate the need for injections for Type 1 diabetics will be commercialized by US company Nuvilex, Inc. and its subsidiaries ...
- Marketwired•2 years agoNuvilex, Inc. Engaged in "Cutting Edge" Cannabis Preclinical Studies Using Model Compounds With Cell-in-a-Box
Nuvilex, Inc. isn't letting the upcoming mid-term elections or the views in Washington, D.C., on medical marijuana slow down its research. The company is currently engaged in preclinical studies at the ...
NUVILEX INC (NVLX)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|